MGC Pharmaceuticals to collaborate with RMIT on research initiatives

Company News

by Jessica Amir

MGC Pharmaceuticals Limited (ASX:MXC) has announced it has signed a landmark agreement with the Royal Melbourne Institute of Technology (RMIT) to collaborate on research initiatives.

As part of the Binding Memorandum of Understanding (MOU) the medicinal cannabis company and RMIT plan to establish a world first ‘International Library of Cannabis Medicine'. 

The collaboration also involves the parties developing genetic and breeding programs that effectively treat specific diseases with medicinal cannabis.

They also plan to develop medical grade cannabis products for future clinical studies in Australia.

Shares in MGC Pharmaceuticals Limited (ASX:MXC) are trading steady at 6.2 cents.

Jessica Amir

Finance News Network
Jessica is a senior finance journalist and presents bulletins including the Market Outlook, Market at Midday and Market Wrap. She also interviews ASX CEOs and leading fund managers. She joined FNN in January 2017 with over six years of broadcast journalism experience including with Sky News Business, ABC 1, ABC's The Business and ABC24. She’s also worked as a TV reporter for Prime 7 and WIN News. Jessica has worked in financial planning for over six years with leading wealth managers and in real estate.